Barclays Raises Hinge Health Price Target to $110 per Share
Barclays kept its Overweight rating on Hinge Health and lifted the stock’s price target to $110 from $100, Benzinga reported at 19:22 GMT.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Barclays maintained its Overweight rating on Hinge Health shares while raising the price target to $110 per share from $100. Benzinga reported the analyst action at 19:22 GMT.
Newsmetry API published the item with a reference to Benzinga’s analyst-ratings page for ticker HNGE.
why it matters
The move represents a change in Barclays’ valuation of Hinge Health while leaving its stock recommendation unchanged. Such revisions can affect market expectations for HNGE shares.
instruments
sources
- Hinge Health Price Target Raised to $110.00/Share From $100.00 by Barclays — Newsmetry API, 12 October 2026 at 19:22 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗